| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 95 | 6.7x | 17.3x | Top tier | |
Growth | 50 | 5.9% | 7.1% | Around median | |
Quality | 75 | 35.0% | 4.5% | Top tier | |
Safety | 48 | 3.4x | 2.6x | Around median | |
Capital Return | 43 | 0.00% | 0.06% | Around median | |
Momentum | 7 | -77.9% | -1.6% | Bottom tier | |
Sentiment | 93 | 10 | 3 | Top tier |
The floor: what the company is worth if growth stopped today
0% of today's price is what a buyer pays for growth that has not happened yet.
10-year US Treasury yield 4.96% as of 2026-10-22. Estimates computed from company data and analyst targets, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
BellRing Brands operates in the protein nutrition market through its Premier Protein and Dymatize brands. The company generates revenue primarily from ready-to-drink protein shakes and protein powders, and drives growth through distribution in food, drug, mass retail, e-commerce, warehouse club, and international channels. Premier Protein is the leading brand in the ready-to-drink protein shake category, while Dymatize benefits from powder sales, price increases, and international expansion.
In Q3 of fiscal 2026, revenue reached $570.4 million, up 4% year over year, and gross profit according to EDGAR filings was approximately $163.3 million, equivalent to a gross margin of about 28.6%. The company recorded net income of $34.2 million, representing a net margin of about 6.0%, and earnings per share of $0.29. By brand, Premier Protein sales increased by only 1%, while Dymatize sales jumped 27%, making Dymatize the fastest growth driver in the mix during the quarter.
Trailing twelve-month data for fiscal 2026 showed revenue of $2.4 billion, gross profit of $673.2 million, net income of $171.4 million, and earnings per share of approximately $1.47. However, adjusted profit in Q3 of fiscal 2026 came under clear pressure; adjusted gross profit was $158 million, and its margin declined to 27.7% from 35.1% a year earlier due to protein cost inflation, freight, tariffs, and a reserve for multipack shake inventory. The current picture therefore combines continued consumer demand and revenue growth on one hand with weak conversion of that demand into stable profit margins on the other.
Analyst consensus rates BRBR shares a “Buy,” with an average price target of $13.2 and a range of $11 to $15; the average equals only about 31% of the 52-week range high of $43.02, while the range low is $7.82. The target's distance from the 52-week high reflects a revaluation associated with declining margins, inventory problems, and protein and freight inflation, while the positive case rests on the potential recovery of fiscal 2027 profitability through pricing and operating savings. The wide gap between the 52-week range and analyst targets indicates that proving the sustainability of the operating recovery is more important than relying on the “Buy” rating alone.
Figures in the text are as of 2026-09-02; the live price is shown at the top of the page.
In Q3 of fiscal 2026, revenue grew 4% to $570.4 million, driven by better-than-expected performance from both Premier Protein and Dymatize. Dymatize sales increased 27%, with 6% volume growth and a 21% improvement in price/mix, while Premier Protein sales increased 1% and its shake volume rose 3%. Accordingly, management raised its fiscal 2026 revenue outlook to $2.335–$2.375 billion, representing growth of between 1% and 3%.
Adjusted gross profit margin fell to 27.7% in Q3 of fiscal 2026 from 35.1% a year earlier due to protein, freight, and tariff inflation. A reserve for excess multipack shake inventory added 180 basis points of pressure, and the recorded reserve was $10 million. The company also expects higher freight to pressure second-half fiscal 2026 margins by approximately 140 basis points and annual adverse inventory impacts to total $28 million.
Premier Protein Ultimate contains 42 grams of protein and targets sports-performance consumers, and the company also considers it suitable for expansion into convenience stores alongside its core 30-gram shake. Premier Protein Sparkling Soda brings the brand into the refreshment category and consumption occasions that differ from traditional shakes. The rollout of both products began in Q4 of fiscal 2026 across mass retail, food, and e-commerce channels, and management expects additional distribution gains during fiscal 2027.
Automated analysis for informational purposes only — not investment advice.
The company intends to implement a double-digit increase on Premier Protein shakes and additional increases on Dymatize powders in Q1 of fiscal 2027. Management believes that pricing, together with annual restructuring savings of $10–$12 million, can begin improving margins during fiscal 2027. However, the plan carries clear risk because the company assumes price elasticity greater than one and faces additional milk protein inflation and persistently elevated whey protein and freight costs.
The company ended Q3 of fiscal 2026 with net leverage of 3.2 times and generated $79 million of operating cash flow during the quarter. It expects to pay a significant legal settlement in Q4 of fiscal 2026, which could raise net leverage to approximately 4 times by the end of the fiscal year. This coincides with the need to invest in advertising, which amounted to approximately 4% of sales, as well as in planning systems, the supply chain, and innovation.
The shares carry a consensus “Buy” rating with an average target of $13.2, a low target of $11, and a high target of $15. The average target is approximately 31% of the 52-week range high of $43.02, while the range low is $7.82. This large gap reflects a revaluation of the company's earnings after adjusted gross margin fell to 27.7%, and therefore an improved outlook depends on proving the impact of pricing and operating savings in fiscal 2027.